{
    "name": "dinutuximab",
    "comment": "Rx",
    "other_names": [
        "Unituxin"
    ],
    "classes": [
        "Antineoplastics",
        "Monoclonal Antibody"
    ],
    "source": "https://reference.medscape.com/drug/unituxin-dinutuximab-1000005",
    "pregnancy": {
        "common": [
            "Based on mechanism of action, fetal harm may occur when administered to a pregnant female",
            "There are no studies in pregnant females and no reproductive studies in animals to inform the drug-associated risk"
        ],
        "specific": [
            {
                "type": "Contraception ",
                "description": [
                    "Females of reproductive potential: Use effective contraception during treatment and for 2 months after final dose"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "No information available on drug presence in human milk, effects on the breastfed infant, or effects on milk production",
            "However, human IgG is present in human milk",
            "Discontinue breastfeeding during treatment"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": [
                {
                    "type": "Infusion reactions",
                    "description": [
                        "Serious and potentially life-threatening infusion reactions occurred in 26% of patients",
                        "Administer required prehydration and premedication, including antihistamines, prior to each dinutuximab infusion",
                        "Monitor closely for signs and symptoms of an infusion reaction during and for at least 4 hr following completion of each dinutuximab infusion",
                        "Immediately interrupt therapy for severe infusion reactions and permanently discontinue dinutuximab for anaphylaxis"
                    ]
                },
                {
                    "type": "Neurotoxicity",
                    "description": [
                        "Causes severe neuropathic pain in the majority of patients",
                        "Administer intravenous opioid prior to, during, and for 2 hr following completion of the infusion",
                        "In clinical studies of patients with high-risk neuroblastoma, grade 3 peripheral sensory neuropathy occurred in 2-9% of patients",
                        "In clinical studies of dinutuximab and related GD2-binding antibodies, severe motor neuropathy was observed in adults",
                        "Resolution of motor neuropathy was not documented in all cases",
                        "Discontinue for severe unresponsive pain, severe sensory neuropathy, or moderate-to-severe peripheral motor neuropathy"
                    ]
                }
            ]
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Infusion reactions may occur; prior to dinutuximab infusion, administer required intravenous hydration and premedication with antihistamines, analgesics, and antipyretics and monitor for signs and symptoms of infusion reactions during and for at least 4 hr following completion of each infusion in a setting where cardiopulmonary resuscitation medication and equipment is available",
                "Abdominal pain, generalized pain, extremity pain, back pain, neuralgia, musculoskeletal pain, and arthralgia reported in dinutuximab/retinoic acid treated group; premdicate with analgesics, including IV opioids, prior to each dose of dinutuximab and continue until 2 hr following completion of dinutuximab; for severe pain, decrease dinutuximab infusion rate to 0.875 mg/mÂ²/hr; discontinue therapy if pain is not adequately controlled despite infusion rate reduction and institution of maximum supportive measures",
                "Permanently discontinue therapy in patients with grade 2 peripheral motor neuropathy, grade 3 sensory neuropathy that interferes with daily activities for more than 2 weeks, or grade 4 sensory neuropathy",
                "Immediately interrupt or discontinue therapy and institute supportive management in patients with symptomatic or severe capillary leak syndrome",
                "Closely monitor blood pressure during treatment; immediately interrupt or discontinue therapy and institute supportive management in patients with symptomatic hypotension, systolic blood pressure less than lower limit of normal for age, or systemic blood pressure that is decreased by more than 15% compared with baseline",
                "Monitor patients for signs and symptoms of systemic infection and temporarily discontinue therapy in patients who develop systemic infection until resolution of infection",
                "Interrupt therapy in patients experiencing dilated pupil with sluggish light reflex or other visual disturbances that do not cause visual loss; upon resolution and if continued treatment with therapy is necessary, decrease dinutuximab dose by 50%; permanently discontinue therapy in patients with recurrent signs of eye disorder following dose reduction and patients who experience vision loss",
                "Bone marrow suppression reported; monitor peripheral blood cell counts closely during therapy",
                "Electrolyte abnormalities reported; monitor serum electrolytes daily during therapy",
                "Atypical hemolytic uremic syndrome reported; permanently discontinue therapy and institute supportive management for signs of the syndrome",
                "Advise pregnant women of the potential risk to a fetus; advise females of reproductive potential to use effective contraception during treatment and for 2 months after the last dose of dinutuximab",
                "Urinary retention that persists for weeks to months following discontinuation of opioids reported; permanently discontinue therapy in patients with urinary retention that does not resolve following discontinuation of opioids",
                "Transverse myelitis reported; promptly evaluate any patient with signs or symptoms of transverse myelitis such as weakness, paresthesia, sensory loss, or incontinence; permanently discontinue therapy in patients who develop transverse myelitis",
                "Reversible Posterior Leukoencephalopathy Syndrome (RPLS) reported; institute appropriate medical treatment and permanently discontinue therapy in patients with signs and symptoms of RPLS (e.g., severe headache, hypertension, visual changes, lethargy, or seizures)"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Pain",
            "percent": "85"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "66"
        },
        {
            "name": "Lymphopenia",
            "percent": "62"
        },
        {
            "name": "Infusion reactions",
            "percent": "60"
        },
        {
            "name": "Hypotension",
            "percent": "60"
        },
        {
            "name": "Hyponatremia",
            "percent": "58"
        },
        {
            "name": "Increased ALT",
            "percent": "56"
        },
        {
            "name": "Anemia",
            "percent": "51"
        },
        {
            "name": "Vomiting",
            "percent": "46"
        },
        {
            "name": "Hypokalemia",
            "percent": "43"
        },
        {
            "name": "Diarrhea",
            "percent": "43"
        },
        {
            "name": "Capillary leak syndrome",
            "percent": "40"
        },
        {
            "name": "Neutropenia",
            "percent": "39"
        },
        {
            "name": "Urticaria",
            "percent": "37"
        },
        {
            "name": "Hypoalbuminemia",
            "percent": "33"
        },
        {
            "name": "Increased AST",
            "percent": "28"
        },
        {
            "name": "Hypocalcemia",
            "percent": "27"
        },
        {
            "name": "Hypoxia",
            "percent": "24"
        },
        {
            "name": "Hypophosphatemia",
            "percent": "20"
        },
        {
            "name": "Tachycardia",
            "percent": "19"
        },
        {
            "name": "Hyperglycemia",
            "percent": "18"
        },
        {
            "name": "Sepsis",
            "percent": "18"
        },
        {
            "name": "Pyrexia",
            "percent": "17"
        },
        {
            "name": "Hemorrhage",
            "percent": "17"
        },
        {
            "name": "Hypertriglyceridemia",
            "percent": "16"
        },
        {
            "name": "Device related infection",
            "percent": "16"
        },
        {
            "name": "Proteinuria",
            "percent": "16"
        },
        {
            "name": "Increased serum creatinine",
            "percent": "15"
        },
        {
            "name": "Decreased appetite",
            "percent": "15"
        },
        {
            "name": "Hypertension",
            "percent": "14"
        },
        {
            "name": "Peripheral neuropathy",
            "percent": "13"
        },
        {
            "name": "Hypomagnesemia",
            "percent": "12"
        },
        {
            "name": "Pain",
            "percent": "77"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "62"
        },
        {
            "name": "Pyrexia",
            "percent": "55"
        },
        {
            "name": "Lymphopenia",
            "percent": "54"
        },
        {
            "name": "Infusion reactions",
            "percent": "47"
        },
        {
            "name": "Hypotension",
            "percent": "43"
        },
        {
            "name": "Increased ALT",
            "percent": "43"
        },
        {
            "name": "Anemia",
            "percent": "42"
        },
        {
            "name": "Diarrhea",
            "percent": "37"
        },
        {
            "name": "Hyponatremia",
            "percent": "36"
        },
        {
            "name": "Vomiting",
            "percent": "33"
        },
        {
            "name": "Hypoalbuminemia",
            "percent": "29"
        },
        {
            "name": "Hypokalemia",
            "percent": "26"
        },
        {
            "name": "Neutropenia",
            "percent": "25"
        },
        {
            "name": "Urticaria",
            "percent": "25"
        },
        {
            "name": "Capillary leak syndrome",
            "percent": "22"
        },
        {
            "name": "Hypocalcemia",
            "percent": "20"
        },
        {
            "name": "Increased AST",
            "percent": "16"
        },
        {
            "name": "Pyrexia",
            "percent": "65"
        },
        {
            "name": "Paine",
            "percent": "61"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "61"
        },
        {
            "name": "Lymphopenia",
            "percent": "61"
        },
        {
            "name": "Hyponatremia",
            "percent": "55"
        },
        {
            "name": "Infusion reactions",
            "percent": "54"
        },
        {
            "name": "Hypotension",
            "percent": "54"
        },
        {
            "name": "Increased ALT",
            "percent": "48"
        },
        {
            "name": "Anemia",
            "percent": "42"
        },
        {
            "name": "Hypokalemia",
            "percent": "39"
        },
        {
            "name": "Diarrhea",
            "percent": "37"
        },
        {
            "name": "Capillary leak syndrome",
            "percent": "36"
        },
        {
            "name": "Vomiting",
            "percent": "35"
        },
        {
            "name": "Neutropenia",
            "percent": "32"
        },
        {
            "name": "Urticaria",
            "percent": "29"
        },
        {
            "name": "Hypoalbuminemia",
            "percent": "29"
        },
        {
            "name": "Increased AST",
            "percent": "21"
        },
        {
            "name": "Hypocalcemia",
            "percent": "21"
        },
        {
            "name": "Pain",
            "percent": "51"
        },
        {
            "name": "Lymphopenia",
            "percent": "51"
        },
        {
            "name": "Pyrexia",
            "percent": "40"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "39"
        },
        {
            "name": "Hypokalemia",
            "percent": "37"
        },
        {
            "name": "Anemia",
            "percent": "34"
        },
        {
            "name": "Neutropenia",
            "percent": "34"
        },
        {
            "name": "Infusion reactions",
            "percent": "25"
        },
        {
            "name": "Hyponatremia",
            "percent": "23"
        },
        {
            "name": "Capillary leak syndrome",
            "percent": "23"
        },
        {
            "name": "Hypotension",
            "percent": "16"
        },
        {
            "name": "Pain",
            "percent": "43"
        },
        {
            "name": "Lymphopenia",
            "percent": "33"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "31"
        },
        {
            "name": "Anemia",
            "percent": "21"
        },
        {
            "name": "Neutropenia",
            "percent": "19"
        },
        {
            "name": "Increased ALT",
            "percent": "15"
        },
        {
            "name": "Hypokalemia",
            "percent": "13"
        },
        {
            "name": "Capillary leak syndrome",
            "percent": "11"
        },
        {
            "name": "Lymphopenia",
            "percent": "50"
        },
        {
            "name": "Pyrexia",
            "percent": "37"
        },
        {
            "name": "Pain",
            "percent": "35"
        },
        {
            "name": "Hypokalemia",
            "percent": "33"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "33"
        },
        {
            "name": "Anemia",
            "percent": "24"
        },
        {
            "name": "Neutropenia",
            "percent": "28"
        },
        {
            "name": "Hyponatremia",
            "percent": "21"
        },
        {
            "name": "Capillary leak syndrome",
            "percent": "20"
        },
        {
            "name": "Infusion reactions",
            "percent": "20"
        },
        {
            "name": "Hypotension",
            "percent": "16"
        },
        {
            "name": "Increased ALT",
            "percent": "13"
        },
        {
            "name": "Diarrhea",
            "percent": "13"
        },
        {
            "name": "Increased weight",
            "percent": "10"
        },
        {
            "name": "Nausea",
            "percent": "10"
        },
        {
            "name": "Hemorrhage",
            "percent": "6"
        },
        {
            "name": "Hypertension",
            "percent": "2"
        },
        {
            "name": "Pyrexia",
            "percent": "10"
        },
        {
            "name": "Infusion reactions",
            "percent": "10"
        },
        {
            "name": "Urticaria",
            "percent": "7"
        },
        {
            "name": "Diarrhea",
            "percent": "6"
        },
        {
            "name": "Hypotension",
            "percent": "5"
        },
        {
            "name": "Hyponatremia",
            "percent": "5"
        },
        {
            "name": "Increased AST",
            "percent": "4"
        },
        {
            "name": "Hypoalbuminemia",
            "percent": "3"
        },
        {
            "name": "Vomiting",
            "percent": "3"
        },
        {
            "name": "Hypocalcemia",
            "percent": "2"
        },
        {
            "name": "Increased AST",
            "percent": "7"
        },
        {
            "name": "Urticaria",
            "percent": "7"
        },
        {
            "name": "Hypocalcemia",
            "percent": "6"
        },
        {
            "name": "Hypoalbuminemia",
            "percent": "5"
        },
        {
            "name": "Vomiting",
            "percent": "2"
        }
    ]
}